Sun Pharma-Ranbaxy deal may come under Sebi lens

The capital markets regulator, Securities and Exchange Board of India, is likely to begin a preliminary inquiry into the $4-billion merger deal between pharma giants Sun Pharmaceutical and Ranbaxy......

Andhra HC order not to impact merger with Ranbaxy: Sun Pharma

Drug major Sun Pharma on Tuesday said its $4-billion merger with Ranbaxy Laboratories will remain on track and the lifting of the stay order issued by the Andhra Pradesh High Court will have no......

Big leap for Sun Pharma, Sunshine for Ranbaxy

With a record of good regulatory compliance, analysts and investors are expecting Sun to soon restore supplies from the troubled factories of Ranbaxy to gain market share in the US and other......

Court orders temporary halt on Sun Pharma's takeover of Ranbaxy

A court has temporarily halted generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of rival Ranbaxy Laboratories Ltd until it decides on a petition for a probe into alleged......